Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Prospective Recurrent Pregnancy Loss Registry 08/14/2023 OBSERVATIONAL unchanged 1,108.85 0 Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 At-home Breast Oncology Care Delivered With E-health Solutions 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 Increasing Access to Fertility Preservation for Women with Breast Cancer 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 Mitigating PTSD-CUD After Sexual Assault 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 The Effect of Pharmacist-Initiated Home Blood Pressure Monitoring on Blood Pressure Control in Women 08/14/2023 INTERVENTIONAL unchanged 1,108.85 0 Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction 08/15/2023 INTERVENTIONAL unchanged 1,107.85 0 Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE 08/15/2023 INTERVENTIONAL unchanged 1,107.85 0 Virtual Body Project Groups Led by Peers Versus Clinicians 08/15/2023 INTERVENTIONAL unchanged 1,107.85 0 Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer 08/16/2023 INTERVENTIONAL unchanged 1,106.85 0 mHealth for Hypertensive Disorder of Pregnancy 08/16/2023 INTERVENTIONAL unchanged 1,106.85 0 Changes in Inhibition and Valuation After Eating 08/16/2023 INTERVENTIONAL unchanged 1,106.85 0 Using Facebook to Support Opioid Recovery Among American Indian Women 08/16/2023 INTERVENTIONAL unchanged 1,106.85 0 Gut and Vaginal Microbiota Profile Study for HIV Women 08/16/2023 OBSERVATIONAL unchanged 1,106.85 0 Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer 08/16/2023 INTERVENTIONAL unchanged 1,106.85 0 Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial 08/18/2023 INTERVENTIONAL unchanged 1,104.85 0 The Effect of a Mindset Management Approach on Stress Levels in Women With Infertility 08/18/2023 INTERVENTIONAL unchanged 1,104.85 0 Parathyroid Tumor Clonal Status 08/18/2023 OBSERVATIONAL unchanged 1,104.85 0 Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder 08/18/2023 INTERVENTIONAL unchanged 1,104.85 0 Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer 08/18/2023 INTERVENTIONAL unchanged 1,104.85 0 A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer 08/21/2023 OBSERVATIONAL unchanged 1,101.85 0 TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 Evaluation of Improvements in Patient-reported Quality of Life 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries 08/21/2023 INTERVENTIONAL unchanged 1,101.85 0 Quality Control of Ultrasound Images During Early Pregnancy Via AI 08/21/2023 OBSERVATIONAL unchanged 1,101.85 0 Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women 08/21/2023 OBSERVATIONAL unchanged 1,101.85 0 Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women 08/22/2023 OBSERVATIONAL unchanged 1,100.85 0 Mothers Working to Prevent Early Stillbirth Study 20-28 08/22/2023 OBSERVATIONAL unchanged 1,100.85 0 Mobile App Logging for Diabetes in Pregnancy 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET) 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Neratinib in Combination With Ruxolitinib in Patients With mTNBC 08/23/2023 INTERVENTIONAL unchanged 1,099.85 0 Midwest Birth Outcomes and Indigenous American Pregnancy 08/23/2023 OBSERVATIONAL unchanged 1,099.85 0 Prevention of Alopecia in Patients With Localised Breast Cancer 08/25/2023 INTERVENTIONAL unchanged 1,097.85 0 Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers 08/28/2023 INTERVENTIONAL unchanged 1,094.85 0 Post-market Prospective Clinical Study of Nagor Perle Mammary Implants 08/28/2023 OBSERVATIONAL unchanged 1,094.85 0 IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer 08/28/2023 INTERVENTIONAL unchanged 1,094.85 0 Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil 08/28/2023 OBSERVATIONAL unchanged 1,094.85 0 Efficacy and Adverse Side Effects of Two Forms of Iron in Pregnancy 08/28/2023 INTERVENTIONAL unchanged 1,094.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology